Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans

Author: Kim Yusung   Toméé Wolfgang A.  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.47, Iss.5, 2008-05, pp. : 906-916

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content